KrASIA:
XtalPi, which makes use of AI for drug discovery and improvement, raises $400M Sequence D led by OrbiMed and RRJ, at a valuation of over $2B — The corporate offers its AI know-how to pharmaceutical firms to boost R&D for brand spanking new medication. — AI pharmaceutical firm XtalPi secured USD 400 million …
[ad_2]
Source link